Blueprint Initiative, BD Diagnostics, BioVision, NIH, NCI, Ciphergen, Milliporem, Wiley-VCH, GeneBio, Shimadzu, University of Tokyo, PerkinElmer, Beckman Coulter, Luminex, Invitrogen, Dynal, NYU | GenomeWeb

Blueprint Lays Off Half its Staff in Face of
Funding Gap, But Says BIND Will Stay Online

The Blueprint Initiative, a non-profit research program housed at the Samuel Lunenfeld Research Institute at Toronto's Mt. Sinai Hospital, was forced to lay off 33 people, or around half its staff, this week as it faces a gap in its funding.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.